Cubist Pharmaceuticals (CBST)

Add to Watchlists
Create an Alert
63.95 +0.02  +0.03% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
CBST Price Chart
View All Events

CBST Events

Date Type Description
Apr 22 Misc Q1 2014 Cubist Pharmaceuticals, Inc. Earnings Call and Webcast
Apr 22 Earnings Q1 2014 Cubist Pharmaceuticals, Inc. Earnings Results. Estimate: 0.34.
Jan 23 Misc 4q & FY2013 Earnings Conference Call and Webcast
Jan 23 Earnings 4Q & FY 2013 Earnings Result. Estimate: 0.33.
Oct 24 Misc Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals
Oct 22 Misc 3Q13 Earnings Conference Call & Webcast
Oct 22 Earnings 3Q13 Earnings Results. Estimate: 0.55.
Sep 11 Misc Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics
Jul 30 Misc Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals
Jul 18 Misc Q2 2013 Earnings Conference Call
View All Performance Charts

CBST Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cubist Pharmaceuticals is up 38.93% over the last year vs S&P 500 Total Return up 23.54%, Biogen Idec up 42.37%, and Celgene up 16.62%.

Get Quote for

PDF Report for CBST

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CBST Pro Report PDF
Advertisement

Portfolio Strategies Featuring CBST

Did Cubist Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CBST Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Cubist Pharmaceuticals is a biopharmaceutical company with activities spanning from research and development to commercialization of pharmaceutical products. Its main products address unmet medical needs in acute care, specifically pathogens like MRSA. Cubist is one of the few firms that have continued to research in antibiotics while larger pharmaceutical companies have abandoned such research. The company employs approximately 700 people, with 370 in their headquarters in Lexington, MA. As of 2011, the company’s headquarters are under expansion and is expected to occupy 373,000 sq ft (34,700 m2) in Lexington. Cubist appeared on Fortune 2010’s List of fastest growing companies, and was named to the 2010 Deloitte Technology Fast 500. In 2006 it had the 19th highest sales among American based biotechnology companies. The company was founded in 1992 and is headquartered in Lexington, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CBST 63.95 +0.02 +0.03% 4.760B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.